NEW YORK, NY / ACCESSWIRE / March 22, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
BTBT Shareholders Click Here: https://www.zlk.com/pslra-1/bit-digital-inc-loss-submission-form?prid=13954&wire=1
ATNX Shareholders Click Here: https://www.zlk.com/pslra-1/athenex-inc-loss-submission-form?prid=13954&wire=1
RIDE Shareholders Click Here: https://www.zlk.com/pslra-1/lordstown-motors-corp-loss-submission-form?prid=13954&wire=1
* ADDITIONAL INFORMATION BELOW *
Bit Digital, Inc. (NASDAQ:BTBT)
BTBT Lawsuit on behalf of: investors who purchased December 21, 2020 - January 8, 2021
Lead Plaintiff Deadline: March 22, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/bit-digital-inc-loss-submission-form?prid=13954&wire=1
According to the filed complaint, during the class period, Bit Digital, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Bit Digital overstated the extent of its a bitcoin mining operation; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Athenex, Inc. (NASDAQ:ATNX)
ATNX Lawsuit on behalf of: investors who purchased August 7, 2019 - February 26, 2021
Lead Plaintiff Deadline: May 3, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/athenex-inc-loss-submission-form?prid=13954&wire=1
According to the filed complaint, during the class period, Athenex, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the data included in the Oral Paclitaxel plus Encequidar NDA presented a safety risk to patients in terms of an increase in neutropenia-related sequalae; (ii) the uncertainty over the results of the primary endpoint of objective response rate (ORR) at week 19 conducted by BICR; (iii) the BICR reconciliation and re-read process may have introduced unmeasured bias and influence on the BICR; (iv) the Company's Phase 3 study that was used to file the NDA was inadequate and not well-conducted in a patient population with metastatic breast cancer representative of the U.S. population, such that the FDA would recommended a new such clinical trial; (v) as a result, it was foreseeable that the FDA would not approve the Company's NDA in its current form; and (vi) as a result, the Company's public statements were materially false and misleading at all relevant times.
Lordstown Motors Corp (NASDAQ:RIDE)
RIDE Lawsuit on behalf of: investors who purchased August 3, 2020 - March 17, 2021
Lead Plaintiff Deadline: May 17, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/lordstown-motors-corp-loss-submission-form?prid=13954&wire=1
According to the filed complaint, during the class period, Lordstown Motors Corp made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's purported pre-orders were non-binding; (ii) many of the would-be customers who made these purported pre-orders lacked the means to make such purchases and/or would not have credible demand for Lordstown's Endurance; (iii) Lordstown is not and has not been "on track" to commence production of the Endurance in September 2021; (iv) the first test run of the Endurance led to the vehicle bursting into flames within 10 minutes; and (v) as a result, the Company's public statements were materially false and misleading at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
https://www.zlk.com
SOURCE: Levi & Korsinsky, LLP